TWA1 promotes the progression of esophageal squamous cell carcinoma via the p38/CXCL2/CXCR2/ERK signaling axis
Current Molecular Pharmacology · 2026 · 19 (1) · 210-224
DOI: 10.1016/j.cmp.2026.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Yuting Wang und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, Y., Zhao, Y., Tang, X., Huang, C., Yu, W., & Zhang, L. (2026). TWA1 promotes the progression of esophageal squamous cell carcinoma via the p38/CXCL2/CXCR2/ERK signaling axis. Current Molecular Pharmacology, 19(1), 210-224. https://doi.org/10.1016/j.cmp.2026.08.002
Vancouver
Wang Y, Zhao Y, Tang X, Huang C, Yu W, Zhang L. TWA1 promotes the progression of esophageal squamous cell carcinoma via the p38/CXCL2/CXCR2/ERK signaling axis. Current Molecular Pharmacology. 2026;19(1):210-224. doi:10.1016/j.cmp.2026.08.002
BibTeX
@article{Wang2026,
author = {Wang, Yuting and Zhao, Yixiao and Tang, Xin and Huang, Chaofan and Yu, Weiyong and Zhang, Li},
title = {TWA1 promotes the progression of esophageal squamous cell carcinoma via the p38/CXCL2/CXCR2/ERK signaling axis},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {210--224},
doi = {10.1016/j.cmp.2026.08.002}
}
EUVIMED